The American Association of Family Physicians’ 2022 clinical practice guideline on blood pressure (BP) targets in adults with hypertension recommends a ceiling target to reduce the risk of all cause and cardiovascular mortality, and a separate target to reduce likelihood of myocardial infarction in those with that risk.
Distinctions between the 2 recommended targets and the supporting evidence, as well as the guidance from the AAFP on making treatment decisions and on attaining and maintaining target blood pressure levels are the topics of the following 10 questions.
Catch up on the 9 FDA drug approvals most relevant to primary care, including new options for HIV-1 infection, narcolepsy, diabetes, pain management, and more.
The CardioGuide HF app from Abbott will show patients their pulmonary artery pressure trends and deliver medication instructions set by their care teams.
FDA has granted IDE approval for the STROKE-REWIRE pivotal trial evaluating NeuWire Medical's neurostimulation device for chronic ischemic stroke recovery.
Stroke incidence in adults aged 20–54 nearly doubled from 1993–1994 to 2020, driven largely by ischemic stroke, while 30-day fatality declined, according to new research.
Capsule-sponge DNA methylation test boosts Barrett’s screening access, showing high accuracy, strong tolerability, and promise for primary care triage to endoscopy.